Tyra Biosciences Correlations
TYRA Stock | USD 14.71 0.06 0.41% |
The current 90-days correlation between Tyra Biosciences and Mineralys Therapeutics, Common is 0.24 (i.e., Modest diversification). The correlation of Tyra Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Tyra Biosciences Correlation With Market
Average diversification
The correlation between Tyra Biosciences and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tyra Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Tyra |
Moving together with Tyra Stock
Moving against Tyra Stock
0.55 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.47 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
0.35 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
0.36 | PTCT | PTC Therapeutics | PairCorr |
0.53 | TGNA | Tegna Inc | PairCorr |
0.5 | FNMFO | Federal National Mortgage | PairCorr |
0.34 | ITCL | Banco Ita Chile | PairCorr |
0.32 | DNOW | Now Inc | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tyra Stock performing well and Tyra Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tyra Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CNTB | 3.87 | (0.13) | 0.00 | 0.21 | 0.00 | 8.66 | 29.84 | |||
RAPT | 7.00 | 0.23 | 0.02 | 0.34 | 9.08 | 10.38 | 119.01 | |||
XLO | 6.31 | 0.19 | (0.01) | 0.00 | 7.55 | 12.00 | 68.31 | |||
MLYS | 3.50 | (0.38) | 0.00 | (0.52) | 0.00 | 7.79 | 26.52 | |||
GRCL | 5.71 | 1.53 | 0.18 | (1.17) | 6.35 | 16.34 | 52.11 | |||
THRX | 5.44 | (0.65) | 0.00 | (0.50) | 0.00 | 11.75 | 90.33 | |||
GLUE | 5.58 | 0.96 | 0.17 | 7.48 | 4.45 | 10.21 | 103.72 | |||
DSGN | 4.39 | (0.06) | 0.00 | (0.13) | 0.00 | 8.72 | 33.11 | |||
ERAS | 3.40 | (0.44) | 0.00 | (0.67) | 0.00 | 6.06 | 26.76 | |||
HOWL | 3.23 | (1.27) | 0.00 | (0.88) | 0.00 | 6.74 | 18.29 |
Tyra Biosciences Corporate Management
CPA CPA | Chief Officer | Profile | |
Sarah Honig | Vice Strategy | Profile | |
Amy Conrad | Investor Contact | Profile | |
Douglas MD | Chief Officer | Profile | |
Hiroomi MD | Chief Officer | Profile | |
Lynn Scherm | F Director | Profile |